These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9187019)

  • 1. The inhibitory effect of heparin for vascular smooth muscle cell proliferation or migration is not mediated by u-PA and t-PA.
    Herbert JM; Bono F; Lamarche I; Carmeliet P
    Thromb Res; 1997 May; 86(4):317-24. PubMed ID: 9187019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells.
    Herbert JM; Lamarche I; Carmeliet P
    J Biol Chem; 1997 Sep; 272(38):23585-91. PubMed ID: 9295297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of u-PA in the anti-apoptotic activity of TGFbeta for vascular smooth muscle cells.
    Herbert JM; Carmeliet P
    FEBS Lett; 1997 Aug; 413(3):401-4. PubMed ID: 9303544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
    Redmond EM; Cahill PA; Hirsch M; Wang YN; Sitzmann JV; Okada SS
    Thromb Haemost; 1999 Feb; 81(2):293-300. PubMed ID: 10064009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery.
    Clowes AW; Clowes MM; Kirkman TR; Jackson CL; Au YP; Kenagy R
    Circ Res; 1992 Jun; 70(6):1128-36. PubMed ID: 1374298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation.
    Xiaoli M; Wenying H; Mingpeng S
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S57-64; discussion S65. PubMed ID: 9951803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
    Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
    Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis.
    Au YP; Kenagy RD; Clowes AW
    J Biol Chem; 1992 Feb; 267(5):3438-44. PubMed ID: 1310687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
    Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE
    Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.
    Herbert JM; Lamarche I; Prabonnaud V; Dol F; Gauthier T
    J Biol Chem; 1994 Jan; 269(4):3076-80. PubMed ID: 8300642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
    Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin inhibits human coronary artery smooth muscle cell migration.
    Kohno M; Yokokawa K; Yasunari K; Minami M; Kano H; Mandal AK; Yoshikawa J
    Metabolism; 1998 Sep; 47(9):1065-9. PubMed ID: 9751234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of estetrol on the endothelial plasminogen pathway and endothelial cell migration.
    Montt-Guevara MM; Palla G; Spina S; Bernacchi G; Cecchi E; Campelo AE; Shortrede JE; Canu A; Simoncini T
    Maturitas; 2017 May; 99():1-9. PubMed ID: 28364860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S; Fukao H; Okada K; Matsuo O
    Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells.
    Yamaguchi M; Diamond S; Watanabe H; Gallati H; Baur W; Sharefkin JB
    In Vitro Cell Dev Biol Anim; 1993 Nov; 29A(11):867-72. PubMed ID: 8167903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice.
    Carmeliet P; Moons L; Herbert JM; Crawley J; Lupu F; Lijnen R; Collen D
    Circ Res; 1997 Nov; 81(5):829-39. PubMed ID: 9351457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
    Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
    Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
    Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity.
    Chen YX; O'Brien ER
    Can J Physiol Pharmacol; 2003 Jul; 81(7):730-9. PubMed ID: 12897821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.